As of 2024-12-12, the EV/EBITDA ratio of Willow Biosciences Inc (WLLW.TO) is -1.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WLLW.TO's latest enterprise value is 12.44 mil CAD. WLLW.TO's TTM EBITDA according to its financial statements is -6.28 mil CAD. Dividing these 2 quantities gives us the above WLLW.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2024-11-29 | -2.22 |
| 2024-11-28 | -2.22 |
| 2024-11-27 | -2.22 |
| 2024-11-26 | -2.10 |
| 2024-11-22 | -2.10 |
| 2024-11-21 | -2.10 |
| 2024-11-20 | -2.10 |
| 2024-11-19 | -1.98 |
| 2024-11-18 | -2.10 |
| 2024-11-15 | -2.47 |
| 2024-11-14 | -2.35 |
| 2024-11-13 | -2.22 |
| 2024-11-12 | -2.35 |
| 2024-11-11 | -2.22 |
| 2024-11-08 | -2.35 |
| 2024-11-07 | -2.47 |
| 2024-11-06 | -2.35 |
| 2024-11-05 | -2.47 |
| 2024-11-01 | -2.35 |
| 2024-10-31 | -2.35 |
| 2024-10-30 | -2.22 |
| 2024-10-29 | -2.22 |
| 2024-10-28 | -2.22 |
| 2024-10-25 | -2.47 |
| 2024-10-24 | -2.47 |
| 2024-10-23 | -2.35 |
| 2024-10-22 | -2.35 |
| 2024-10-21 | -2.35 |
| 2024-10-18 | -2.35 |
| 2024-10-17 | -2.59 |
| 2024-10-16 | -2.47 |
| 2024-10-15 | -2.47 |
| 2024-10-11 | -2.59 |
| 2024-10-10 | -2.47 |
| 2024-10-09 | -2.47 |
| 2024-10-08 | -2.47 |
| 2024-10-07 | -2.59 |
| 2024-10-04 | -2.47 |
| 2024-10-03 | -2.59 |
| 2024-10-02 | -2.71 |
| 2024-10-01 | -2.71 |
| 2024-09-30 | -2.71 |
| 2024-09-27 | -2.59 |
| 2024-09-26 | -2.59 |
| 2024-09-25 | -2.59 |
| 2024-09-24 | -2.59 |
| 2024-09-23 | -2.59 |
| 2024-09-20 | -2.59 |
| 2024-09-19 | -2.47 |
| 2024-09-18 | -2.35 |